Gary L Johnson

9PUBLICATIONS

96CO-AUTHORS

Gene and molecular therapyMolecular targetsNeurology and neuromuscular diseasesPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 10, 2026

The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart.

|Feb 05, 2025

Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.

Smita Matkar, Michael P East, Timothy J Stuhlmiller

|Dec 05, 2024

Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches.

Yi Xu, Xianlu L Peng, Michael P East

|Jul 05, 2023

Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.

Alyssa C Flint, Dana K Mitchell, Steven P Angus

|May 13, 2021

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036.

Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta

|May 11, 2021

Limited inhibition of multiple nodes in a driver network blocks metastasis.

Ali Ekrem Yesilkanal, Dongbo Yang, Andrea Valdespino

Pageof 2

Frequent Collaborators

Steven P Angus

Chi Zhang

Shawn M Gomez

Michael L Gatza

Michael P East

Lisa A Carey

Samantha G Pattenden

Brian C Jensen

Sourav Bandyopadhyay

Ali Ekrem Yesilkanal

Frequent Collaborators

Steven P Angus

Chi Zhang

Shawn M Gomez

Michael L Gatza